Safety first at FDA

Regulation

FDA's new Safety First initiative will focus at least as much attention on postmarket safety as the agency devotes to premarket reviews, and drive regulators to publicize drug safety signals before knowing what they mean and without any clear guidance on how doctors and patients should respond to the information. ...